Nitric oxide and its derivatives in the cancer battlefield.
暂无分享,去创建一个
Michal Wozniak | Stephan Nussberger | S. Nussberger | M. Wozniak | D. Jacewicz | M. Górska-Ponikowska | Alicja Kuban-Jankowska | Anna Kamm | Paulina Przychodzen | Alicja Kuban-Jankowska | Dagmara Jacewicz | Aleksandra M Dabrowska | Magdalena Gorska-Ponikowska | Paulina Przychodzeń | A. Kamm | A. Dąbrowska
[1] A. Stern,et al. Nitric oxide: Protein tyrosine phosphorylation and protein S-nitrosylation in cancer , 2015, Biomedical journal.
[2] Yu-Chao Wang,et al. Heat-activated sustaining nitric oxide release from zwitterionic diazeniumdiolate loaded in thermo-sensitive liposomes. , 2010, Nitric oxide : biology and chemistry.
[3] N. Hogg,et al. Cancer cell metabolism and the modulating effects of nitric oxide. , 2015, Free radical biology & medicine.
[4] B. Brüne,et al. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. , 1997, Kidney international.
[5] R. Jain,et al. The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.
[6] R. Stephens,et al. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. , 2010, The Journal of clinical investigation.
[7] M. Kirsch,et al. Formation of Peroxynitrite from Reaction of Nitroxyl Anion with Molecular Oxygen* , 2002, Journal of Biological Chemistry.
[8] M. Gladwin,et al. Nitrate and nitrite in biology, nutrition and therapeutics. , 2009, Nature chemical biology.
[9] M. N. Hughes,et al. Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. , 1999, Biochimica et biophysica acta.
[10] William L. Jorgensen,et al. The Organic Chemist's Book of Orbitals , 1973 .
[11] Giosuè Lo Bosco,et al. 2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells. , 2018, Cancer genomics & proteomics.
[12] L. Oberley,et al. Superoxide dismutase activity of Ehrlich ascites tumor cells. , 1977, Journal of the National Cancer Institute.
[13] C. Cross,et al. Formation of Reactive Nitrogen Species during Peroxidase-catalyzed Oxidation of Nitrite , 1997, The Journal of Biological Chemistry.
[14] E. Mazzon,et al. Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells , 2018, Molecules.
[15] M. Gladwin,et al. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Żmijewski,et al. Neuronal Nitric Oxide Synthase Induction in the Antitumorigenic and Neurotoxic Effects of 2-Methoxyestradiol , 2014, Molecules.
[17] D. Wink,et al. Biological nitric oxide signalling: chemistry and terminology , 2013, British journal of pharmacology.
[18] Bonnie A. Merchant,et al. Nitrite Reductase and Nitric-oxide Synthase Activity of the Mitochondrial Molybdopterin Enzymes mARC1 and mARC2* , 2014, The Journal of Biological Chemistry.
[19] W. Pryor,et al. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. , 1995, The American journal of physiology.
[20] A. Denicola,et al. Nitrogen dioxide solubility and permeation in lipid membranes. , 2011, Archives of biochemistry and biophysics.
[21] T. Galeotti,et al. Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissues. , 1975, Biochimica et biophysica acta.
[22] B. Bonavida,et al. Mechanisms of nitric oxide-mediated inhibition of EMT in cancer , 2010, Cell cycle.
[23] J. Otte,et al. Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells. , 2010, Neoplasia.
[24] J. K. Hurst,et al. CO2-Catalyzed One-Electron Oxidations by Peroxynitrite: Properties of the Reactive Intermediate , 1998 .
[25] B. Freeman,et al. Olives and Olive Oil Are Sources of Electrophilic Fatty Acid Nitroalkenes , 2014, PloS one.
[26] C. Giulivi,et al. Biochemistry of Mitochondrial Nitric-oxide Synthase* , 2002, The Journal of Biological Chemistry.
[27] J. Stephenson,et al. Vibrational predissociation of the nitric oxide dimer: Total energy distribution in the fragments , 1986 .
[28] K. Kashfi,et al. The dual role of iNOS in cancer☆ , 2015, Redox biology.
[29] B. Freeman,et al. Formation and signaling actions of electrophilic lipids. , 2011, Chemical reviews.
[30] L. Ignarro,et al. In Vivo Aspects of Nitric Oxide (NO) Chemistry: Does Peroxynitrite (-OONO) Play a Major Role in Cytotoxicity? , 1997 .
[31] R. Mendel,et al. Molybdenum cofactor biosynthesis and molybdenum enzymes. , 2006, Annual review of plant biology.
[32] A. Morelli,et al. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. , 2003, Gastroenterology.
[33] M. Gordon,et al. Structures, Bonding, and Energetics of N2O2 Isomers , 1994 .
[34] W. Pryor,et al. Rates and mechanisms of reactions of nitrogen dioxide with alkenes in solution , 1987 .
[35] A. Ahluwalia,et al. Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite , 2008, Hypertension.
[36] C. Ratanatawanate,et al. S-nitrosocysteine-decorated PbS QDs/TiO2 nanotubes for enhanced production of singlet oxygen. , 2011, Journal of the American Chemical Society.
[37] A. Girotti,et al. Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy. , 2016, Current medicinal chemistry.
[38] D. Matei,et al. Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial. , 2009, Gynecologic oncology.
[39] J. Zweier,et al. Characterization of the Magnitude and Mechanism of Aldehyde Oxidase-mediated Nitric Oxide Production from Nitrite* , 2009, The Journal of Biological Chemistry.
[40] D. Zhu,et al. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. , 2009, Nitric oxide : biology and chemistry.
[41] C. Yiannoutsos,et al. A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer , 2005, Clinical Cancer Research.
[42] M. Kirsch,et al. The Pathobiochemistry of Nitrogen Dioxide , 2002, Biological chemistry.
[43] M. Haigis,et al. Mitochondria and Cancer , 2016, Cell.
[44] Tianxin Yang,et al. Protection of nitro-fatty acid against kidney diseases. , 2016, American journal of physiology. Renal physiology.
[45] D. Busija,et al. Mitochondrial nitric oxide synthase: current concepts and controversies. , 2009, Frontiers in bioscience.
[46] M. Harrison,et al. A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC) , 2011, Investigational New Drugs.
[47] P. Richardson,et al. Novel Therapy with 2-Methoxyestradiol for the Treatment of Relapsed and Plateau Phase Multiple Myeloma , 2007, Clinical Cancer Research.
[48] J. McCubrey,et al. The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt , 2009, Molecular Cancer Therapeutics.
[49] J. Patel,et al. Influence of epithelial lining fluid lipids on NO(2)-induced membrane oxidation and nitration. , 2003, Free radical biology & medicine.
[50] S. Ambs,et al. Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. , 2011, Trends in pharmacological sciences.
[51] Wangling,et al. Sulfite Oxidase Catalyzes Single-Electron Transfer at Molybdenum Domain to Reduce Nitrite to Nitric Oxide. , 2015, Antioxidants & redox signaling.
[52] A. Gadbail,et al. Nitric oxide and cancer: a review , 2013, World Journal of Surgical Oncology.
[53] E. Weitzberg,et al. The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. , 2008, Nitric oxide : biology and chemistry.
[54] B. Mayer,et al. Protein Tyrosine Nitration in Cytokine-activated Murine Macrophages , 2001, The Journal of Biological Chemistry.
[55] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[56] Jianhua Zhang,et al. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling , 2011, The Biochemical journal.
[57] V. Poornima,et al. Nitric oxide and oral cancer: a review. , 2012, Oral oncology.
[58] C. Lindermayr,et al. Nitric oxide-based protein modification: formation and site-specificity of protein S-nitrosylation , 2013, Front. Plant Sci..
[59] A. Friebe,et al. This Review Is Part of a Thematic Series on Cyclic Gmp–generating Enzymes and Cyclic Gmp–dependent Signaling, Which Includes the following Articles: Regulation of Nitric Oxide–sensitive Guanylyl Cyclase Cyclic Gmp Phosphodiesterases and Regulation of Smooth Muscle Function Structure, Regulation, and , 2022 .
[60] L. Liaudet,et al. Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.
[61] BasudharDebashree,et al. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression. , 2017 .
[62] Z. Iqbal,et al. Role of nitrogen dioxide in the biosynthesis of nitraosamines in mice. , 1980, Science.
[63] D. Wink,et al. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[64] E. Werner,et al. Metabolic Fate of Peroxynitrite in Aqueous Solution , 1997, The Journal of Biological Chemistry.
[65] S. Steinberg,et al. Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors , 2006, Cancer biology & therapy.
[66] Y. Janssen-Heininger,et al. In situ analysis of protein S-glutathionylation in lung tissue using glutaredoxin-1-catalyzed cysteine derivatization. , 2009, The American journal of pathology.
[67] Jifeng Zhang,et al. Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators* , 2006, Journal of Biological Chemistry.
[68] D. Townsend,et al. S-Glutathionylation of Protein Disulfide Isomerase Regulates Estrogen Receptor α Stability and Function , 2012, International journal of cell biology.
[69] J. Fukuto,et al. Chemistry of nitric oxide: biologically relevant aspects. , 1995, Advances in pharmacology.
[70] Robert M. Rapoport,et al. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation , 1983, Nature.
[71] R. Eisenthal,et al. Reduction of organic nitrites to nitric oxide catalyzed by xanthine oxidase: possible role in metabolism of nitrovasodilators. , 2000, Biochemical and biophysical research communications.
[72] E. Cavalli,et al. The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K. , 2015, Leukemia research.
[73] D. Deamer,et al. Superoxide dismutase activity in WI-38 cell cultures: effects of age, trypsinization and SV-40 transformation. , 1974, Physiological chemistry and physics.
[74] Jun Yang,et al. Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase , 2014, Proceedings of the National Academy of Sciences.
[75] B. Zhivotovsky,et al. Mitophagy: Link to cancer development and therapy. , 2017, Biochemical and biophysical research communications.
[76] P. Puigserver,et al. PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors. , 2016, Trends in cancer.
[77] Guy C. Brown. Nitric oxide and mitochondria. , 2007, Frontiers in bioscience : a journal and virtual library.
[78] Jeannette Bigler,et al. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics , 2006, Nature Reviews Cancer.
[79] E. Kool,et al. Hydrophobic, Non-Hydrogen-Bonding Bases and Base Pairs in DNA. , 1995, Journal of the American Chemical Society.
[80] A. Seabra,et al. Nitric oxide donor superparamagnetic iron oxide nanoparticles. , 2013, Materials science & engineering. C, Materials for biological applications.
[81] S. Ferng,et al. DNA strand breaks caused by exposure to ozone and nitrogen dioxide. , 1999, Environmental research.
[82] S. Glynn,et al. The yin and yang of nitric oxide in cancer progression. , 2013, Carcinogenesis.
[83] E. Clementi,et al. Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide , 2003, Science.
[84] B. Freeman,et al. Nitro-fatty acid pharmacokinetics in the adipose tissue compartment[S] , 2017, Journal of Lipid Research.
[85] A. Vanin,et al. Nitric oxide synthase reduces nitrite to NO under anoxia , 2006, Cellular and Molecular Life Sciences.
[86] J. Hetzler,et al. Product energy correlations in the dissociation of overtone excited nitric oxide dimer , 1991 .
[87] G. Merényi,et al. Tyrosine Nitration by Simultaneous Generation of ⋅NO and O⨪2 under Physiological Conditions , 2000, The Journal of Biological Chemistry.
[88] A. Schechter,et al. Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits , 2011, European journal of nutrition.
[89] B. Mayer,et al. A New Pathway of Nitric Oxide/Cyclic GMP Signaling InvolvingS-Nitrosoglutathione* , 1998, The Journal of Biological Chemistry.
[90] A. Martínez-Ruíz,et al. S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells. , 2011, Gastroenterology.
[91] F. Kassie,et al. Nitric oxide-donating aspirin (NO-Aspirin) suppresses lung tumorigenesis in vitro and in vivo and these effects are associated with modulation of the EGFR signaling pathway , 2018, Carcinogenesis.
[92] Li Gao,et al. Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins. , 2012, International journal of oncology.
[93] G. Squadrito,et al. On the hydrophobicity of nitrogen dioxide: could there be a "lens" effect for NO(2) reaction kinetics? , 2009, Nitric oxide : biology and chemistry.
[94] D. Atochin,et al. Nitric oxide and mitochondria in metabolic syndrome , 2015, Front. Physiol..
[95] J. K. Hurst,et al. Hydroxyl Radical Formation during Peroxynitrous Acid Decomposition , 1999 .
[96] S Moncada,et al. Nitric oxide synthases in mammals. , 1994, The Biochemical journal.
[97] Chandan K Sen,et al. Mitochondrial nitric oxide synthase. , 2005, Trends in pharmacological sciences.
[98] C. Harris,et al. Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[99] D. Wink,et al. Modulation of Superoxide-dependent Oxidation and Hydroxylation Reactions by Nitric Oxide (*) , 1996, The Journal of Biological Chemistry.
[100] J. Schrader,et al. Control of coronary vascular tone by nitric oxide. , 1990, Circulation research.
[101] Saranya Rajendran,et al. Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling. , 2019, Comprehensive Physiology.
[102] L. Ignarro,et al. Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[103] Lucas B. Sullivan,et al. Mitochondrial reactive oxygen species and cancer , 2014, Cancer & Metabolism.
[104] H. Ohshima,et al. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. , 2006, Nitric oxide : biology and chemistry.
[105] James K. G. Watson,et al. THE NO DIMER : 15N ISOTOPIC INFRARED SPECTRA, LINE-WIDTHS, AND FORCE FIELD , 1995 .
[106] J. Meyerhardt,et al. A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors , 2011, Cancer Chemotherapy and Pharmacology.
[107] G. Wilding,et al. A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate , 2012, Investigational New Drugs.
[108] D. Townsend,et al. Causes and Consequences of Cysteine S-Glutathionylation* , 2013, The Journal of Biological Chemistry.
[109] K. Appel,et al. Niltrogen dioxide induces DNA single-strand breaks in cultured Chinese hamster cells , 1990 .
[110] N. Bryan,et al. Cellular targets and mechanisms of nitros(yl)ation: An insight into their nature and kinetics in vivo , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[111] S. Shiva. Mitochondria as metabolizers and targets of nitrite. , 2010, Nitric oxide : biology and chemistry.
[112] S. Rodríguez-Enríquez,et al. Selective degradation of mitochondria by mitophagy. , 2007, Archives of biochemistry and biophysics.
[113] G. Sledge,et al. Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer , 2006, Investigational New Drugs.
[114] C. Cooper,et al. Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.
[115] C. Sen,et al. Mitochondrial nitric oxide synthase. , 2007, Frontiers in bioscience : a journal and virtual library.
[116] S. Ambs,et al. S-Nitrosation Mediates Multiple Pathways That Lead to Tumor Progression in Estrogen Receptor-Negative Breast Cancer. , 2012, Forum on immunopathological diseases and therapeutics.
[117] D. Naughton,et al. Human xanthine oxidase converts nitrite ions into nitric oxide (NO). , 1997, Biochemical Society transactions.
[118] M. Wozniak,et al. Nitro-oxidative Stress Is Involved in Anticancer Activity of 17β-Estradiol Derivative in Neuroblastoma Cells. , 2016, Anticancer research.
[119] N. Davidson,et al. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth , 2017, The Journal of Biological Chemistry.
[120] Francesca Benedini,et al. Positional Isomerism Markedly Affects the Growth Inhibition of Colon Cancer Cells by Nitric Oxide-Donating Aspirin in Vitro and in Vivo , 2005, Journal of Pharmacology and Experimental Therapeutics.
[121] M. Marinus,et al. Nitric Oxide-Induced Homologous Recombination in Escherichia coli Is Promoted by DNA Glycosylases , 2002, Journal of bacteriology.
[122] A. Girotti. Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy , 2018, Lasers in surgery and medicine.
[123] G. Wilding,et al. Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies , 2009, Clinical Cancer Research.
[124] A. Girotti,et al. Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation , 2019, Cancers.
[125] J. Hodgson,et al. Dietary Nitrate, Nitric Oxide, and Cardiovascular Health , 2016, Critical reviews in food science and nutrition.
[126] M. Ciriolo,et al. Nuclear Recruitment of Neuronal Nitric-oxide Synthase by α-Syntrophin Is Crucial for the Induction of Mitochondrial Biogenesis* , 2013, The Journal of Biological Chemistry.
[127] C. Giulivi,et al. Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. , 2010, Free radical biology & medicine.
[128] M. Donia,et al. In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells , 2011, Cell cycle.
[129] Mark T. Gladwin,et al. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics , 2008, Nature Reviews Drug Discovery.
[130] Liying Wang,et al. S-Nitrosylation of Bcl-2 Inhibits Its Ubiquitin-Proteasomal Degradation , 2006, Journal of Biological Chemistry.
[131] A. Volterra,et al. Differential Modulation of the Uptake Currents by Redox Interconversion of Cysteine Residues in the Human Neuronal Glutamate Transporter EAAC1 , 1997, The European journal of neuroscience.
[132] G. Reiser,et al. The ionization energy of nitric oxide , 1988 .
[133] B. Mayer,et al. Lack of Tyrosine Nitration by Peroxynitrite Generated at Physiological pH* , 1998, The Journal of Biological Chemistry.
[134] A. Denicola,et al. Diffusion and Transport of Reactive Species Across Cell Membranes. , 2019, Advances in experimental medicine and biology.
[135] M. Wozniak,et al. Effect of 2-Methoxyestradiol on Dephosphorylation of Neuronal Nitric Oxide Synthase in Osteosarcoma 143B Cells. An in vitro study , 2015 .
[136] C. Piantadosi,et al. Redox regulation of mitochondrial biogenesis. , 2012, Free radical biology & medicine.
[137] J. M. Marchetti,et al. Nanocarriers for Nitric Oxide Delivery , 2011, Journal of drug delivery.
[138] B. Freeman,et al. Generation and esterification of electrophilic fatty acid nitroalkenes in triacylglycerides. , 2015, Free radical biology & medicine.
[139] S. Padmaja,et al. The reaction of no with superoxide. , 1993, Free radical research communications.
[140] D. Wink,et al. Nitric Oxide I . Physiological chemistry of nitric oxide and its metabolites : implications in inflammation , 1999 .
[141] G. Semenza,et al. Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.
[142] D. Wink,et al. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. , 1998, Free radical biology & medicine.
[143] J. Murrell,et al. Structure and stability of the nitric oxide dimer , 1971 .
[144] R. Cress,et al. Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.
[145] Jenny C. Chang,et al. Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast Cancer , 2018, Clinical Cancer Research.
[146] V. Rohde,et al. Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors , 2014, Neurosurgical Review.
[147] M. Calderón,et al. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives. , 2015, Current topics in medicinal chemistry.
[148] A. L. East. The 16 valence electronic states of nitric oxide dimer (NO)2 , 1998 .
[149] L. Hofseth,et al. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. , 2007, Cancer research.
[150] R. Kaufman,et al. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? , 2007, Antioxidants & redox signaling.
[151] L. Oberley. Mechanism of the tumor suppressive effect of MnSOD overexpression. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[152] S. Goldstein,et al. Formation of Peroxynitrate from the Reaction of Peroxynitrite with CO2: Evidence for Carbonate Radical Production , 1998 .
[153] J. Watson,et al. The intermolecular vibrations of the NO dimer , 1998 .
[154] P. Mouthuy,et al. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) , 2017, Redox biology.
[155] J. Drapier,et al. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. , 1986, The Journal of clinical investigation.
[156] F. Cappello,et al. DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anti-cancer effect of 2-methoxyestradiol , 2015, Oncotarget.
[157] C. Leifert,et al. Dietary nitrate in man: friend or foe? , 1999, British Journal of Nutrition.
[158] F. W. Flitney,et al. NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. , 1995, Trends in pharmacological sciences.
[159] Fang Li,et al. Regulation of HIF-1α Stability through S-nitrosylation , 2007 .
[160] Jae Ho Shin,et al. Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth. , 2010, Molecular pharmaceutics.
[161] B. Halliwell,et al. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. , 1996, The Biochemical journal.
[162] H. Bergh,et al. The heat of formation of the nitric oxide dimer and its UV spectrum , 1978 .
[163] N. Bryan,et al. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. , 2009, The American journal of clinical nutrition.
[164] E. Mazzon,et al. Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo , 2019, Investigational New Drugs.
[165] B. Banecki,et al. Pivotal participation of nitrogen dioxide in L-arginine induced acute necrotizing pancreatitis: protective role of superoxide scavenger 4-OH-TEMPO. , 2005, Biochemical and biophysical research communications.
[166] B. Oronsky,et al. The Implications of Hyponitroxia in Cancer , 2014, Translational oncology.
[167] S. Stoltze,et al. Nitrate and nitrite in vegetables on the Danish market: content and intake. , 1999, Food additives and contaminants.
[168] Lingqun Zhu,et al. iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer , 2017, Oncotarget.
[169] A. Kim. Modulation of MnSOD in Cancer:Epidemiological and Experimental Evidence , 2010, Toxicological research.
[170] Wei Chen,et al. Myricitrin protects against peroxynitrite-mediated DNA damage and cytotoxicity in astrocytes. , 2013, Food chemistry.
[171] F. Traganos,et al. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention. , 2001, Cancer research.
[172] J. Wierzbicka,et al. Role of Oxidative and Nitro-Oxidative Damage in Silver Nanoparticles Cytotoxic Effect against Human Pancreatic Ductal Adenocarcinoma Cells , 2018, Oxidative medicine and cellular longevity.
[173] L. Folkes,et al. DNA damage induced by nitric oxide during ionizing radiation is enhanced at replication. , 2013, Nitric oxide : biology and chemistry.
[174] K. Houk,et al. Mechanisms of peroxynitrite-mediated nitration of tyrosine. , 2009, Chemical research in toxicology.
[175] S. Berchmans,et al. Nitric oxide releasing photoresponsive nanohybrids as excellent therapeutic agent for cervical cancer cell lines. , 2013, ACS Applied Materials and Interfaces.
[176] H. E. Marshall,et al. Protein S-nitrosylation: purview and parameters , 2005, Nature Reviews Molecular Cell Biology.
[177] T. Mak,et al. Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.
[178] G. Shapiro,et al. ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors , 2016, Cancer Chemotherapy and Pharmacology.
[179] V. Bowry,et al. The Complex Chemistry of Peroxynitrite Decomposition: New Insights1 , 1998 .
[180] K. Schmidt,et al. Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[181] A. Kozlov,et al. Nitrite reductase activity is a novel function of mammalian mitochondria , 1999, FEBS letters.
[182] Lech Chmurzynski,et al. A Novel Biosensor for Evaluation of Apoptotic or Necrotic Effects of Nitrogen Dioxide during Acute Pancreatitis in Rat , 2009, Sensors.
[183] S. Qian,et al. Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer. , 2019, Nitric oxide : biology and chemistry.
[184] E. Weitzberg,et al. A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. , 2008, Nature chemical biology.
[185] S. Rybárová,et al. Expression of peptidergic and nitrergic structures in dorsal root ganglia of the rabbit. , 2000, European journal of histochemistry : EJH.
[186] Min Guan,et al. Anti-HIV drugs for cancer therapeutics: back to the future? , 2009, The Lancet. Oncology.
[187] G. Chaudhuri,et al. Nitric-oxide-induced Bax integration into the mitochondrial membrane commits MDA-MB-468 cells to apoptosis: essential role of Akt. , 2003, Cancer research.
[188] K. Kashfi,et al. Nitric-oxide-donating NSAIDs as agents for cancer prevention. , 2004, Trends in molecular medicine.
[189] R. Radi. Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine , 2018, Proceedings of the National Academy of Sciences.
[190] S. Ambs,et al. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression , 2014, Proceedings of the National Academy of Sciences.
[191] S. Cai,et al. Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma. , 2012, Biomaterials.
[192] A. Girotti. Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide , 2016, Cancers.
[193] R. Mendel,et al. Molybdenum cofactors, enzymes and pathways , 2009, Nature.
[194] Y. E. Chen,et al. Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts. , 2013, Cardiovascular research.
[195] R. Hille,et al. Mechanism of nitrite-dependent NO synthesis by human sulfite oxidase. , 2019, The Biochemical journal.
[196] E. Ford,et al. Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH. , 2002, Free radical biology & medicine.
[197] Shazia Khan,et al. Interactions of Nitric Oxide and Redox-related species with biological targets , 1995 .
[198] M. Dikshit,et al. Cdk2 nitrosylation and loss of mitochondrial potential mediate NO-dependent biphasic effect on HL-60 cell cycle. , 2010, Free radical biology & medicine.
[199] M. P. Cole,et al. Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. , 2010, Cardiovascular research.